medigraphic.com

2014, Number 2

<< Back Next >>

Rev Med Inst Mex Seguro Soc 2014; 52 (2)

Heart-failure importance and utility of the echocardiographic evaluation

Echeverri-Rico JV, Aceves-Millán R, Amezcua-Gómez L, Ixcamparij-Rosales CH, Ruiz-Rivero A, Torres A, Majluf-Cruz A

Language: Spanish
References: 26
Page: 188-191
PDF size: 53.77 Kb.


ABSTRACT

Millions of people die every year due to cardiovascular diseases. The objective against these diseases is primary prevention, but secondary prevention is the major goal in those individuals who already suffered an event. The order of the cardiovascular complication is the next one: arrhythmia, heart failure, myocardial infarction or stroke, and death. Approximately between 1 and 2 % of adults present heart failure, but this percentage rises to more than 10 % in adults over 70 years. Therefore, it is necessary to diagnose and to treat this complication. Left ventricular ejection fraction is the most important prognosis factor in these patients, because it decreases in 50 % of them. Almost 50 % of patients with heart failure have a conserved systolic function, but a decreased diastolic function. Treatment must improve the structural and functional heart abnormalities. Echocardiography is a useful tool in these patients due to its exactitude, accessibility, safety, and low cost. It provides information about the characteristics of the cardiac chambers and its volumes, the diameter in the walls, and about the diastolic, systolic and valvular function. Recently, echocardiography evolved to third dimension techniques, which seem to be more exact. In the next years, we will have more evidence about this diagnostic modality.


REFERENCES

  1. Secretaría de Salud. Encuesta Nacional de Salud 2012. Ensanut 2012. México: Secretaría de Salud; 2012.

  2. Sherazi S, Zareba W. Diastolic heart failure: predictors of mortality. Cardiol J. 2011;18(3):222-32.

  3. Kardys I, Deckers JW, Stricker BHCh, Vletter WB, Hofman A, Witteman J. Eur J Epidemiol. 2010;25 (7):481-90.

  4. Shaya FT, Breunig IM, Mehra MR. Budget impacts of potential modifi cation of risk factors for heart failure hospitalizations: A contemporary Medicaid cohort analysis. Value Health. 2013;16(3):A278-9.

  5. Klein A, Grimm R, Murray R, Apperson-Hansen C, Asinger RW, Black IW, et al. Use of transesophageal echocardiography to guide cardioversion in patients with atrial fi brillation. N Engl J Med. 2001;344(19): 1411-20.

  6. Robertson J, McElduff P, Pearson SA, Henry DA, Inder KJ, Attia JR. Correction: the health services burden of heart failure: An analysis using linked population health data-sets. BMC Health Serv Res. 2013;13:179.

  7. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2012;33(14): 1787-847.

  8. Iwano H, Little WC. Heart failure: What does ejection fraction have to do with it? J Cardiol. 2013;62(1):1-3.

  9. Lang R, Bierig M, Devereux R, Flachskampf FA, Foster E, Pellikka PA, et al. Recommendations for chamber quantifi cation: A report from the American Society of Echocardiography’s Nomenclature and Standards Committee and the Task Force on Chamber Quantifi - cation. Eur J Echocardiogr. 2006;7(2):79-108.

  10. Sallach J, Tang W, Borowski A, Tong W, Porter T, Martin MG, et al. Right atrial volume index in chronic systolic heart failure and prognosis. JACC Cardiovasc Imaging. 2009;2(5):527-34.

  11. Watanabe T, Iwai-Takano M, Oikawa M, Yamaki T, Yaoita H, Maruyama Y. Optimal noninvasive assessment of diastolic heart failure in patients with atrial fi brillation: Comparison of tissue doppler echocardiography, left atrium size, and brain natriuretic peptide. J Am Soc Echocardiogr. 2008;21(6):689-96.

  12. Peterson GE, Brickner ME, Reimold SC. Transesophageal echocardiography clinical indications and applications. Circulation. 2003;107(19):2398-402.

  13. Aune E, Baekkevar M, Roislien J, Rodevand O, Otterstad JE. Normal reference ranges for left and right atrial volume indexes and ejection fractions obtained with real-time three-dimensional echocardiography. Eur J Echocardiography. 2009;10(6):738-44.

  14. Leung D, Chi C, Allman C. Prognostic implications of left atrial volume index in patients in sinus rhythm. Am J Cardiol. 2010;105(11):1635-9.

  15. Aliti GB, Rabelo ER, Clausell N, Rohde LE, Biolo A, Beck-da-Silva L. Aggressive fl uid and sodium restriction in acute decompensated heart failure: a randomized clinical trial. JAMA Intern Med. 2013; 173(12):1058-64.

  16. Joffe SW, Dewolf M, Shih J, McManus DD, Spencer FA, Lessard D, et al. Trends in the medical management of patients with heart failure. J Clin Med Res. 2013;5(3):194-204.

  17. Rohde LE, Bertoldi EG, Goldraich L, Polanczyk CA. Cost-effectiveness of heart failure therapies. Nat Rev Cardiol. 2013;10(6):338-54.

  18. Pepi M, Evangelista A, Nihoyannopoulos P, Flachskampf FA, Athanassopoulos G, Colonna P, et al. Recommendations for echocardiography use in the diagnosis and management of cardiac sources of embolism. Eur J Echocardiogr. 2010;11(6):461-76.

  19. Keller A, Gopal A, King D. Left and right atrial volume by freehand three-dimensional echocardiography: in vivo validation using magnetic resonance imaging. Eur J Echocardiogr. 2000;1(1):55-65.

  20. Rudski LG, Lai WW. Guidelines for the echocardiographic assessment of the right heart in adults: A report from the American Society of Echocardiography. J Am Soc Echocardiogr. 2010;23(7):685-713.

  21. Kleemann T, Becker T, Strauss M, Schneider S, Seidl K. Prevalence of left atrial thrombus and dense spontaneous echocontrast in patients with shortterm atrial fi brillation < 48 hours undergoing cardioversion: Value of transesophageal echocardiography to guide cardioversion. J Am Soc Echocardiogr. 2009;22(12):1403-8.

  22. Shahgaldi K, Manouras A, Abrahamsson A, Gudmundsson P, Brodin LA, Winter R. Three-dimensional echocardiography using single-heartbeat modality decreases variability in measuring left ventricular volumes and function in comparison to four-beat technique in atrial fi brillation. Cardiovasc Ultrasound. 2010;8(1):45.

  23. Smith DH, Thorp ML, Gurwitz JH, McManus DD, Goldberg RJ, Allen LA, et al. Chronic kidney disease and outcomes in heart failure with preserved versus reduced ejection fraction: The Cardiovascular Research Network PRESERVE Study. Circ Cardiovasc Qual Outcomes. 2013;6(3):333-42.

  24. Kannel WB, Benjamin EJ. Status of the epidemiology of atrial fi brillation. Med Clin North Am. 2008;92 (1):17-40.

  25. Indik J, Alpert J. The patient with atrial fi brillation. Am J Med. 2009;122(5):415-8.

  26. Spevack DM, Karl J, Yedlapati N, Goldberg Y, Garcia MJ. Echocardiographic left ventricular end-diastolic pressure volume loop estimate predicts survival in congestive heart failure. J Card Fail. 2013; 19(4):251-9.




2020     |     www.medigraphic.com